|
Martin Nicklasson, born 1955, was educated at the Pharmaceutical Faculty, University of Uppsala (Pharmacist and PhD in Pharmaceutical Technology). Since 1985, he is Associate Professor at the Department of Pharmaceutics, University of Uppsala, and since 1990 Adjunct Associate Professor, College of Pharmacy, University of Cincinnati. He joined Astra in 1978 and held a number of research posts from 1979 to 1988. He moved to KABI in 1989 as Head of R&D in one of the Business Units, but joined Astra again in 1991 as President of Astra Pain Control AB and was appointed President of Astra Hässle AB in 1996. Between 1998 and 2002 he was Executive Vice President of the Astra and AstraZeneca Gastrointestinal Franchise. From July 2002 to December 2004 inclusive, he was Executive Vice President of Global Drug Development in AstraZeneca, and from January 2005 he is Executive Vice President, Global Marketing.
| 